Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. Unlike in a ...
Six years after COVID-19 first reached New Zealand, the country is experiencing its ninth wave of infections. But the virus we are living with today behaves very differently from the one that caused ...
Every week has brought new developments, new hearings, new appointments, and new announcements in the world of vaccine policy ...
My first concert review for Exclaim! was a wake-up call about what going to shows would look like going forward in the COVID-19 era. I felt a little betrayed by the safety measures I was promised at ...
A federal judge blocked parts of HHS's vaccine policy changes, siding with medical groups against Robert F. Kennedy Jr.'s agenda.
For the study, published yesterday in Science Advances, a team led by a Stanford University investigator used machine learning (artificial intelligence) trained on US death certificates to predict ...
The Trump administration faces complicated political dynamics as it seeks someone to helm the key public health agency ...
The 2024-2025 mRNA COVID-19 vaccine provided moderate protection against severe outcomes, including hospitalizations and ED visits.
Six years after COVID-19 first reached New Zealand, the country is experiencing its ninth wave of infections .Authors Michael Plank Professor in ...
A fourth dose of bivalent or monovalent BA.1-adapted BNT162b2 vaccines was safe and elicited robust neutralizing responses in adults aged 18 to 55 years.
The future of the US Centers for Disease Control and Prevention’s panel of vaccine advisers is unclear, even among its recently appointed members.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results